APO Research
Talk to an analyst

APO RESEARCH · REPORT

Palonosetron

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Palonosetron Market Outlook and Growth Opportunities 2026

22 December 2025196 pages

Choose your research edition.

Industry ResearchPalonosetron Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Palonosetron Industry Growth and Trends Forecast to 2032109 pages · $3,450 USDMarket StructureGlobal Palonosetron Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Palonosetron Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Palonosetron Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Palonosetron market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Palonosetron is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Palonosetron is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Palonosetron is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Palonosetron market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Palonosetron market include Teva, Sichuan Hairong Pharmaceutical, Qilu Pharmaceutical, Pfizer, Fresenius Kabi, Jiangsu Aosaikang Pharmaceutical, Sagent Pharmaceuticals, Helsinn Therapeutics and Exela Pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Palonosetron market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Palonosetron and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Palonosetron sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Palonosetron market size, projected growth trends, production technologies, key applications, and end-use industries.

Palonosetron Segment by Company

Teva

Sichuan Hairong Pharmaceutical

Qilu Pharmaceutical

Pfizer

Fresenius Kabi

Jiangsu Aosaikang Pharmaceutical

Sagent Pharmaceuticals

Helsinn Therapeutics

Exela Pharma

Dr. Reddys Laboratories

Cipla

Palonosetron Segment by Type

Injection 0.25 mg/5 mL

Injection 20 mcg/kg (max 1.5 mg)

Palonosetron Segment by Application

Adults

Children

Palonosetron Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Palonosetron status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Palonosetron market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Palonosetron significant trends, drivers, influence factors in global and regions.

6. To analyze Palonosetron competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Palonosetron market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Palonosetron and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Palonosetron.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Palonosetron market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Palonosetron industry.

Chapter 3: Detailed analysis of Palonosetron manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Palonosetron in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Palonosetron in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Palonosetron Industry Trends Table 2. Palonosetron Industry Drivers Table 3. Palonosetron Industry Opportunities and Challenges Table 4. Palonosetron Industry Restraints Table 5. Global Palonosetron Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Palonosetron Revenue Share by Company (2021-2026) Table 7. Global Palonosetron Sales Volume by Company (k units) & (2021-2026) Table 8. Global Palonosetron Sales Volume Share by Company (2021-2026) Table 9. Global Palonosetron Average Price (US$/unit) of Company (2021-2026) Table 10. Global Palonosetron Company Ranking, (2024-2026) & (USD Million) Table 11. Global Palonosetron Key Company Manufacturing Base & Headquarters Table 12. Global Palonosetron Company, Product Type & Application Table 13. Global Palonosetron Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Palonosetron by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Injection 0.25 mg/5 mL Table 18. Significant Companies of Injection 20 mcg/kg (max 1.5 mg) Table 19. Global Palonosetron Sales Volume by Type 2021 VS 2025 VS 2032 (k units) Table 20. Global Palonosetron Sales Volume by Type (2021-2026) & (k units) Table 21. Global Palonosetron Sales Volume by Type (2027-2032) & (k units) Table 22. Global Palonosetron Sales Volume Share by Type (2021-2026) Table 23. Global Palonosetron Sales Volume Share by Type (2027-2032) Table 24. Global Palonosetron Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Palonosetron Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Palonosetron Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Palonosetron Sales Value Share by Type (2021-2026) Table 28. Global Palonosetron Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Adults Table 30. Significant Companies of Children Table 31. Global Palonosetron Sales Volume by Application 2021 VS 2025 VS 2032 (k units) Table 32. Global Palonosetron Sales Volume by Application (2021-2026) & (k units) Table 33. Global Palonosetron Sales Volume by Application (2027-2032) & (k units) Table 34. Global Palonosetron Sales Volume Share by Application (2021-2026) Table 35. Global Palonosetron Sales Volume Share by Application (2027-2032) Table 36. Global Palonosetron Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Palonosetron Sales Value by Application (2021-2026) & (US$ Million) Table 38. Global Palonosetron Sales Value by Application (2027-2032) & (US$ Million) Table 39. Global Palonosetron Sales Value Share by Application (2021-2026) Table 40. Global Palonosetron Sales Value Share by Application (2027-2032) Table 41. Global Palonosetron Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 42. Global Palonosetron Sales by Region (2021-2026) & (k units) Table 43. Global Palonosetron Sales Market Share by Region (2021-2026) Table 44. Global Palonosetron Sales by Region (2027-2032) & (k units) Table 45. Global Palonosetron Sales Market Share by Region (2027-2032) Table 46. Global Palonosetron Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Palonosetron Sales Value by Region (2021-2026) & (US$ Million) Table 48. Global Palonosetron Sales Value Share by Region (2021-2026) Table 49. Global Palonosetron Sales Value by Region (2027-2032) & (US$ Million) Table 50. Global Palonosetron Sales Value Share by Region (2027-2032) Table 51. Global Palonosetron Market Average Price (US$/unit) by Region (2021-2026) Table 52. Global Palonosetron Market Average Price (US$/unit) by Region (2027-2032) Table 53. Global Palonosetron Sales by Country: 2021 VS 2025 VS 2032 (k units) Table 54. Global Palonosetron Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 55. Global Palonosetron Sales by Country (2021-2026) & (k units) Table 56. Global Palonosetron Sales Market Share by Country (2021-2026) Table 57. Global Palonosetron Sales by Country (2027-2032) & (k units) Table 58. Global Palonosetron Sales Market Share by Country (2027-2032) Table 59. Global Palonosetron Sales Value by Country (2021-2026) & (US$ Million) Table 60. Global Palonosetron Sales Value Market Share by Country (2021-2026) Table 61. Global Palonosetron Sales Value by Country (2027-2032) & (US$ Million) Table 62. Global Palonosetron Sales Value Market Share by Country (2027-2032) Table 63. Teva Company Information Table 64. Teva Business Overview Table 65. Teva Palonosetron Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 66. Teva Palonosetron Product Portfolio Table 67. Teva Recent Development Table 68. Sichuan Hairong Pharmaceutical Company Information Table 69. Sichuan Hairong Pharmaceutical Business Overview Table 70. Sichuan Hairong Pharmaceutical Palonosetron Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 71. Sichuan Hairong Pharmaceutical Palonosetron Product Portfolio Table 72. Sichuan Hairong Pharmaceutical Recent Development Table 73. Qilu Pharmaceutical Company Information Table 74. Qilu Pharmaceutical Business Overview Table 75. Qilu Pharmaceutical Palonosetron Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 76. Qilu Pharmaceutical Palonosetron Product Portfolio Table 77. Qilu Pharmaceutical Recent Development Table 78. Pfizer Company Information Table 79. Pfizer Business Overview Table 80. Pfizer Palonosetron Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 81. Pfizer Palonosetron Product Portfolio Table 82. Pfizer Recent Development Table 83. Fresenius Kabi Company Information Table 84. Fresenius Kabi Business Overview Table 85. Fresenius Kabi Palonosetron Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 86. Fresenius Kabi Palonosetron Product Portfolio Table 87. Fresenius Kabi Recent Development Table 88. Jiangsu Aosaikang Pharmaceutical Company Information Table 89. Jiangsu Aosaikang Pharmaceutical Business Overview Table 90. Jiangsu Aosaikang Pharmaceutical Palonosetron Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 91. Jiangsu Aosaikang Pharmaceutical Palonosetron Product Portfolio Table 92. Jiangsu Aosaikang Pharmaceutical Recent Development Table 93. Sagent Pharmaceuticals Company Information Table 94. Sagent Pharmaceuticals Business Overview Table 95. Sagent Pharmaceuticals Palonosetron Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 96. Sagent Pharmaceuticals Palonosetron Product Portfolio Table 97. Sagent Pharmaceuticals Recent Development Table 98. Helsinn Therapeutics Company Information Table 99. Helsinn Therapeutics Business Overview Table 100. Helsinn Therapeutics Palonosetron Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 101. Helsinn Therapeutics Palonosetron Product Portfolio Table 102. Helsinn Therapeutics Recent Development Table 103. Exela Pharma Company Information Table 104. Exela Pharma Business Overview Table 105. Exela Pharma Palonosetron Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 106. Exela Pharma Palonosetron Product Portfolio Table 107. Exela Pharma Recent Development Table 108. Dr. Reddys Laboratories Company Information Table 109. Dr. Reddys Laboratories Business Overview Table 110. Dr. Reddys Laboratories Palonosetron Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 111. Dr. Reddys Laboratories Palonosetron Product Portfolio Table 112. Dr. Reddys Laboratories Recent Development Table 113. Cipla Company Information Table 114. Cipla Business Overview Table 115. Cipla Palonosetron Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 116. Cipla Palonosetron Product Portfolio Table 117. Cipla Recent Development Table 118. Key Raw Materials Table 119. Raw Materials Key Suppliers Table 120. Palonosetron Distributors List Table 121. Palonosetron Customers List Table 122. Research Programs/Design for This Report Table 123. Authors List of This Report Table 124. Secondary Sources Table 125. Primary Sources List of Figures Figure 1. Palonosetron Product Image Figure 2. Global Palonosetron Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Palonosetron Sales Value (2021-2032) & (US$ Million) Figure 4. Global Palonosetron Sales (2021-2032) & (k units) Figure 5. Global Palonosetron Sales Average Price (US$/unit) & (2021-2032) Figure 6. Global Palonosetron Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Injection 0.25 mg/5 mL Image Figure 10. Injection 20 mcg/kg (max 1.5 mg) Image Figure 11. Global Palonosetron Sales Volume by Type (2021 VS 2025 VS 2032) & (k units) Figure 12. Global Palonosetron Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Palonosetron Sales Volume Share by Type (2021-2032) Figure 14. Global Palonosetron Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Palonosetron Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Palonosetron Sales Value Share by Type (2021-2032) Figure 17. Adults Image Figure 18. Children Image Figure 19. Global Palonosetron Sales Volume by Application (2021 VS 2025 VS 2032) & (k units) Figure 20. Global Palonosetron Sales Volume Share 2021 VS 2025 VS 2032 Figure 21. Global Palonosetron Sales Volume Share by Application (2021-2032) Figure 22. Global Palonosetron Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Palonosetron Sales Value Share 2021 VS 2025 VS 2032 Figure 24. Global Palonosetron Sales Value Share by Application (2021-2032) Figure 25. Global Palonosetron Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 26. Global Palonosetron Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 27. Global Palonosetron Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 28. Global Palonosetron Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 29. North America Palonosetron Sales Value (2021-2032) & (US$ Million) Figure 30. North America Palonosetron Sales Value Share by Country (%), 2025 VS 2032 Figure 31. Europe Palonosetron Sales Value (2021-2032) & (US$ Million) Figure 32. Europe Palonosetron Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Asia-Pacific Palonosetron Sales Value (2021-2032) & (US$ Million) Figure 34. Asia-Pacific Palonosetron Sales Value Share by Country (%), 2025 VS 2032 Figure 35. South America Palonosetron Sales Value (2021-2032) & (US$ Million) Figure 36. South America Palonosetron Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Middle East & Africa Palonosetron Sales Value (2021-2032) & (US$ Million) Figure 38. Middle East & Africa Palonosetron Sales Value Share by Country (%), 2025 VS 2032 Figure 39. USA Palonosetron Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. USA Palonosetron Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. USA Palonosetron Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. Canada Palonosetron Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. Canada Palonosetron Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. Canada Palonosetron Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Mexico Palonosetron Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Mexico Palonosetron Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Mexico Palonosetron Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Germany Palonosetron Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Germany Palonosetron Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Germany Palonosetron Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. France Palonosetron Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. France Palonosetron Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. France Palonosetron Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. U.K. Palonosetron Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. U.K. Palonosetron Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. U.K. Palonosetron Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Italy Palonosetron Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Italy Palonosetron Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Italy Palonosetron Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Spain Palonosetron Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Spain Palonosetron Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Spain Palonosetron Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Russia Palonosetron Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Russia Palonosetron Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Russia Palonosetron Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Netherlands Palonosetron Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Netherlands Palonosetron Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Netherlands Palonosetron Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Nordic Countries Palonosetron Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Nordic Countries Palonosetron Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Nordic Countries Palonosetron Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. China Palonosetron Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. China Palonosetron Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. China Palonosetron Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Japan Palonosetron Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Japan Palonosetron Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Japan Palonosetron Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. South Korea Palonosetron Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. South Korea Palonosetron Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. South Korea Palonosetron Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. India Palonosetron Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. India Palonosetron Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. India Palonosetron Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Australia Palonosetron Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Australia Palonosetron Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Australia Palonosetron Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Southeast Asia Palonosetron Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Southeast Asia Palonosetron Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Southeast Asia Palonosetron Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Brazil Palonosetron Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Brazil Palonosetron Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Brazil Palonosetron Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Argentina Palonosetron Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Argentina Palonosetron Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Argentina Palonosetron Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Chile Palonosetron Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Chile Palonosetron Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Chile Palonosetron Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Colombia Palonosetron Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Colombia Palonosetron Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Colombia Palonosetron Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Peru Palonosetron Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Peru Palonosetron Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Peru Palonosetron Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Saudi Arabia Palonosetron Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Saudi Arabia Palonosetron Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Palonosetron Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Israel Palonosetron Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Israel Arabia Palonosetron Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Israel Arabia Palonosetron Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. UAE Palonosetron Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. UAE Palonosetron Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. UAE Palonosetron Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Turkey Palonosetron Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Turkey Palonosetron Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Turkey Palonosetron Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Iran Palonosetron Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Iran Palonosetron Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Iran Palonosetron Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Egypt Palonosetron Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Egypt Palonosetron Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Egypt Palonosetron Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Palonosetron Value Chain Figure 124. Manufacturing Cost Structure Figure 125. Palonosetron Sales Mode & Process Figure 126. Direct Comparison with Distribution Share Figure 127. Distributors Profiles Figure 128. Years Considered Figure 129. Research Process Figure 130. Key Executives Interviewed

Scope & coverage.

Types
  • Injection 0.25 mg/5 mL
  • Injection 20 mcg/kg (max 1.5 mg)
Applications
  • Adults
  • Children
Companies covered
  • Teva
  • Sichuan Hairong Pharmaceutical
  • Qilu Pharmaceutical
  • Pfizer
  • Fresenius Kabi
  • Jiangsu Aosaikang Pharmaceutical
  • Sagent Pharmaceuticals
  • Helsinn Therapeutics
  • Exela Pharma
  • Dr. Reddys Laboratories
  • Cipla

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Palonosetron Sales Value (2021-2032)
  4. 1.2.2 Global Palonosetron Sales Volume (2021-2032)
  5. 1.2.3 Global Palonosetron Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Palonosetron Market Dynamics
  1. 2.1 Palonosetron Industry Trends
  2. 2.2 Palonosetron Industry Drivers
  3. 2.3 Palonosetron Industry Opportunities and Challenges
  4. 2.4 Palonosetron Industry Restraints
3 Palonosetron Market by Company
  1. 3.1 Global Palonosetron Company Revenue Ranking in 2025
  2. 3.2 Global Palonosetron Revenue by Company (2021-2026)
  3. 3.3 Global Palonosetron Sales Volume by Company (2021-2026)
  4. 3.4 Global Palonosetron Average Price by Company (2021-2026)
  5. 3.5 Global Palonosetron Company Ranking (2024-2026)
  6. 3.6 Global Palonosetron Company Manufacturing Base and Headquarters
  7. 3.7 Global Palonosetron Company Product Type and Application
  8. 3.8 Global Palonosetron Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Palonosetron Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Palonosetron Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Palonosetron Market by Type
  1. 4.1 Palonosetron Type Introduction
  2. 4.1.1 Injection 0.25 mg/5 mL
  3. 4.1.2 Injection 20 mcg/kg (max 1.5 mg)
  4. 4.2 Global Palonosetron Sales Volume by Type
  5. 4.2.1 Global Palonosetron Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Palonosetron Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Palonosetron Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Palonosetron Sales Value by Type
  9. 4.3.1 Global Palonosetron Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Palonosetron Sales Value by Type (2021-2032)
  11. 4.3.3 Global Palonosetron Sales Value Share by Type (2021-2032)
5 Palonosetron Market by Application
  1. 5.1 Palonosetron Application Introduction
  2. 5.1.1 Adults
  3. 5.1.2 Children
  4. 5.2 Global Palonosetron Sales Volume by Application
  5. 5.2.1 Global Palonosetron Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Palonosetron Sales Volume by Application (2021-2032)
  7. 5.2.3 Global Palonosetron Sales Volume Share by Application (2021-2032)
  8. 5.3 Global Palonosetron Sales Value by Application
  9. 5.3.1 Global Palonosetron Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Palonosetron Sales Value by Application (2021-2032)
  11. 5.3.3 Global Palonosetron Sales Value Share by Application (2021-2032)
6 Palonosetron Regional Sales and Value Analysis
  1. 6.1 Global Palonosetron Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Palonosetron Sales by Region (2021-2032)
  3. 6.2.1 Global Palonosetron Sales by Region: 2021-2026
  4. 6.2.2 Global Palonosetron Sales by Region (2027-2032)
  5. 6.3 Global Palonosetron Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Palonosetron Sales Value by Region (2021-2032)
  7. 6.4.1 Global Palonosetron Sales Value by Region: 2021-2026
  8. 6.4.2 Global Palonosetron Sales Value by Region (2027-2032)
  9. 6.5 Global Palonosetron Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Palonosetron Sales Value (2021-2032)
  12. 6.6.2 North America Palonosetron Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Palonosetron Sales Value (2021-2032)
  15. 6.7.2 Europe Palonosetron Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Palonosetron Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Palonosetron Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Palonosetron Sales Value (2021-2032)
  21. 6.9.2 South America Palonosetron Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Palonosetron Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Palonosetron Sales Value Share by Country, 2025 VS 2032
7 Palonosetron Country-level Sales and Value Analysis
  1. 7.1 Global Palonosetron Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Palonosetron Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Palonosetron Sales by Country (2021-2032)
  4. 7.3.1 Global Palonosetron Sales by Country (2021-2026)
  5. 7.3.2 Global Palonosetron Sales by Country (2027-2032)
  6. 7.4 Global Palonosetron Sales Value by Country (2021-2032)
  7. 7.4.1 Global Palonosetron Sales Value by Country (2021-2026)
  8. 7.4.2 Global Palonosetron Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Palonosetron Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Palonosetron Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Palonosetron Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Palonosetron Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Palonosetron Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Palonosetron Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Palonosetron Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Palonosetron Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Palonosetron Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Palonosetron Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Palonosetron Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Palonosetron Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Palonosetron Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Palonosetron Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Palonosetron Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Palonosetron Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Palonosetron Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Palonosetron Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Palonosetron Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Palonosetron Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Palonosetron Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Palonosetron Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Palonosetron Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Palonosetron Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Palonosetron Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Palonosetron Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Palonosetron Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Palonosetron Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Palonosetron Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Palonosetron Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Palonosetron Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Palonosetron Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Palonosetron Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Palonosetron Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Palonosetron Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Palonosetron Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Palonosetron Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Palonosetron Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Palonosetron Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Palonosetron Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Palonosetron Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Palonosetron Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Palonosetron Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Palonosetron Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Palonosetron Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Palonosetron Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Palonosetron Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Palonosetron Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Palonosetron Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Palonosetron Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Palonosetron Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Palonosetron Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Palonosetron Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Palonosetron Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Palonosetron Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Palonosetron Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Palonosetron Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Palonosetron Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Palonosetron Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Palonosetron Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Palonosetron Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Palonosetron Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Palonosetron Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Palonosetron Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Palonosetron Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Palonosetron Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Palonosetron Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Palonosetron Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Palonosetron Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Palonosetron Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Palonosetron Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Palonosetron Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Palonosetron Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Palonosetron Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Palonosetron Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Palonosetron Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Palonosetron Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Palonosetron Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Palonosetron Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Palonosetron Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Palonosetron Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Palonosetron Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Palonosetron Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Palonosetron Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Teva
  2. 8.1.1 Teva Company Information
  3. 8.1.2 Teva Business Overview
  4. 8.1.3 Teva Palonosetron Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Teva Palonosetron Product Portfolio
  6. 8.1.5 Teva Recent Developments
  7. 8.2 Sichuan Hairong Pharmaceutical
  8. 8.2.1 Sichuan Hairong Pharmaceutical Company Information
  9. 8.2.2 Sichuan Hairong Pharmaceutical Business Overview
  10. 8.2.3 Sichuan Hairong Pharmaceutical Palonosetron Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Sichuan Hairong Pharmaceutical Palonosetron Product Portfolio
  12. 8.2.5 Sichuan Hairong Pharmaceutical Recent Developments
  13. 8.3 Qilu Pharmaceutical
  14. 8.3.1 Qilu Pharmaceutical Company Information
  15. 8.3.2 Qilu Pharmaceutical Business Overview
  16. 8.3.3 Qilu Pharmaceutical Palonosetron Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Qilu Pharmaceutical Palonosetron Product Portfolio
  18. 8.3.5 Qilu Pharmaceutical Recent Developments
  19. 8.4 Pfizer
  20. 8.4.1 Pfizer Company Information
  21. 8.4.2 Pfizer Business Overview
  22. 8.4.3 Pfizer Palonosetron Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Pfizer Palonosetron Product Portfolio
  24. 8.4.5 Pfizer Recent Developments
  25. 8.5 Fresenius Kabi
  26. 8.5.1 Fresenius Kabi Company Information
  27. 8.5.2 Fresenius Kabi Business Overview
  28. 8.5.3 Fresenius Kabi Palonosetron Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Fresenius Kabi Palonosetron Product Portfolio
  30. 8.5.5 Fresenius Kabi Recent Developments
  31. 8.6 Jiangsu Aosaikang Pharmaceutical
  32. 8.6.1 Jiangsu Aosaikang Pharmaceutical Company Information
  33. 8.6.2 Jiangsu Aosaikang Pharmaceutical Business Overview
  34. 8.6.3 Jiangsu Aosaikang Pharmaceutical Palonosetron Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Jiangsu Aosaikang Pharmaceutical Palonosetron Product Portfolio
  36. 8.6.5 Jiangsu Aosaikang Pharmaceutical Recent Developments
  37. 8.7 Sagent Pharmaceuticals
  38. 8.7.1 Sagent Pharmaceuticals Company Information
  39. 8.7.2 Sagent Pharmaceuticals Business Overview
  40. 8.7.3 Sagent Pharmaceuticals Palonosetron Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Sagent Pharmaceuticals Palonosetron Product Portfolio
  42. 8.7.5 Sagent Pharmaceuticals Recent Developments
  43. 8.8 Helsinn Therapeutics
  44. 8.8.1 Helsinn Therapeutics Company Information
  45. 8.8.2 Helsinn Therapeutics Business Overview
  46. 8.8.3 Helsinn Therapeutics Palonosetron Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Helsinn Therapeutics Palonosetron Product Portfolio
  48. 8.8.5 Helsinn Therapeutics Recent Developments
  49. 8.9 Exela Pharma
  50. 8.9.1 Exela Pharma Company Information
  51. 8.9.2 Exela Pharma Business Overview
  52. 8.9.3 Exela Pharma Palonosetron Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Exela Pharma Palonosetron Product Portfolio
  54. 8.9.5 Exela Pharma Recent Developments
  55. 8.10 Dr. Reddys Laboratories
  56. 8.10.1 Dr. Reddys Laboratories Company Information
  57. 8.10.2 Dr. Reddys Laboratories Business Overview
  58. 8.10.3 Dr. Reddys Laboratories Palonosetron Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Dr. Reddys Laboratories Palonosetron Product Portfolio
  60. 8.10.5 Dr. Reddys Laboratories Recent Developments
  61. 8.11 Cipla
  62. 8.11.1 Cipla Company Information
  63. 8.11.2 Cipla Business Overview
  64. 8.11.3 Cipla Palonosetron Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Cipla Palonosetron Product Portfolio
  66. 8.11.5 Cipla Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Palonosetron Value Chain Analysis
  2. 9.1.1 Palonosetron Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Palonosetron Sales Mode & Process
  6. 9.2 Palonosetron Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Palonosetron Distributors
  9. 9.2.3 Palonosetron Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst